A high aldosterone result matters most when renin is suppressed, blood pressure is difficult to control, or potassium runs low. The number alone rarely diagnoses the cause.
- Aldosterone test results suggest primary aldosteronism when aldosterone is inappropriately high, renin is low, and hypertension or low potassium is present.
- Renin test results help separate primary aldosteronism from dehydration, kidney artery narrowing, diuretic effects, and heart or kidney disease.
- Aldosterone renin ratio is often considered positive when ARR is above 20-30 ng/dL per ng/mL/h with aldosterone at least 10-15 ng/dL, but lab units change the cutoff.
- Primary aldosteronism is found in roughly 5-10% of all hypertension and up to about 20% of resistant hypertension in specialist studies.
- Potassium is usually 3.5-5.0 mmol/L in adults; levels below 3.5 mmol/L make excess aldosterone more suspicious, especially without a clear medication cause.
- Medication effects are common: spironolactone, eplerenone, amiloride, diuretics, beta blockers, ACE inhibitors, and ARBs can all distort renin or aldosterone.
- Confirmatory testing may include saline infusion, oral sodium loading, captopril challenge, or fludrocortisone suppression after a positive screening result.
- Before repeating an abnormal result, ask about salt intake, potassium correction, posture, time of day, assay units, and whether blood pressure medicines should be adjusted safely.
What an aldosterone test result can and cannot diagnose
An aldosterone test suggests primary aldosteronism when aldosterone is high for the situation, renin is suppressed, and the patient has hypertension, low potassium, or both. By itself, aldosterone is not enough; a stressed, dehydrated, salt-restricted, or diuretic-treated body can raise aldosterone appropriately.
As of June 8, 2026, most endocrine hypertension clinics still treat the aldosterone result as a context marker, not a yes-or-no diagnosis. A seated morning aldosterone of 18 ng/dL may be suspicious if plasma renin activity is below 1.0 ng/mL/h, but the same aldosterone can be physiologic after sodium restriction or volume loss.
I’m Thomas Klein, MD, and when I review this pattern clinically, the first question I ask is boring but decisive: what was the blood pressure and potassium on the same week? A potassium of 3.1 mmol/L with blood pressure 158/96 mmHg tells a very different story from potassium 4.4 mmol/L and a normal home blood pressure log.
Kantesti is an AI blood test analyzer that reads aldosterone beside potassium, sodium, bicarbonate, creatinine, blood pressure context, and medication timing rather than treating one hormone as a standalone flag. That matters because patients often upload isolated PDF pages; our doctors see many cases where the answer is hidden in the surrounding chemistry, not the hormone line itself.
If you are staring at a flagged value without notes, start by translating the number, unit, collection position, and companion tests before assuming adrenal disease. Our guide to blood test numbers is a useful primer for that kind of pattern reading.
When high aldosterone points to primary aldosteronism
High aldosterone points toward primary aldosteronism when it remains elevated despite low renin, especially in resistant hypertension, spontaneous low potassium, or an adrenal incidental finding. The classic screen is aldosterone, renin, and the aldosterone renin ratio drawn under controlled conditions.
The 2016 Endocrine Society guideline recommends screening people with resistant hypertension, hypertension plus low potassium, hypertension with an adrenal incidentaloma, sleep apnea with hypertension, or a family history of early hypertension or stroke before age 40 (Funder et al., 2016). In clinic, I add one more practical trigger: a patient needing three medicines before age 50 deserves a careful look.
Primary aldosteronism is not rare. Brown and colleagues found biochemical evidence across the hypertension spectrum, with rates rising from about 11% in stage 1 hypertension to more than 20% in resistant hypertension in a 2020 Annals of Internal Medicine study (Brown et al., 2020).
The blood pressure clue is often subtle. Many patients sit around 142-152 systolic for years, feel well, and are told they have ordinary essential hypertension until potassium drops after a thiazide or the ARR is finally checked.
Use home readings if clinic values bounce around. For background on pressure categories and why repeated measurements matter, see our guide to blood pressure ranges.
Why the renin test changes the meaning of aldosterone
A renin test tells you whether aldosterone is being driven by the kidney-renin system or being produced too independently. Low renin with high aldosterone is the biochemical signature that makes primary aldosteronism plausible.
Renin is the upstream signal. When blood volume is low or kidney perfusion is reduced, renin rises and aldosterone follows; when aldosterone is autonomous, sodium is retained, volume expands, and renin is usually suppressed below about 1.0 ng/mL/h by plasma renin activity.
Kantesti AI interprets aldosterone test patterns by separating low-renin states from high-renin states, because both can show aldosterone above the lab reference range. A renin result of 8 ng/mL/h with aldosterone 25 ng/dL often suggests secondary aldosterone activation, while renin 0.2 ng/mL/h with the same aldosterone points in a very different direction.
This is why potassium, bicarbonate, and kidney function matter. Excess aldosterone can push potassium down and bicarbonate up, so a basic chemistry pattern can quietly support the hormone result; our electrolyte panel guide explains those shifts in plain language.
A renin result can be reported as plasma renin activity in ng/mL/h or direct renin concentration in mU/L or pg/mL. Those methods are not interchangeable, and I have seen perfectly smart patients compare the wrong reference ranges after switching laboratories.
How to read the aldosterone renin ratio without unit traps
The aldosterone renin ratio is a screening ratio, not a final diagnosis. Many laboratories treat ARR above 20-30 ng/dL per ng/mL/h as positive when aldosterone is at least 10-15 ng/dL, but cutoffs change with assay and units.
One common pattern is plasma aldosterone concentration of 15 ng/dL or higher with plasma renin activity below 1.0 ng/mL/h, producing an ARR above 20-30. In SI units, 10 ng/dL of aldosterone is about 277 pmol/L, and some direct-renin laboratories use cutoffs around 70 pmol/mU, but local validation wins.
Kantesti’s neural network checks unit compatibility before commenting on ARR, because a ng/dL-to-pmol/L mix-up can create a 27.7-fold interpretation error. If your report changed from PRA to direct renin concentration, do not compare the ratio with your old cutoff.
The numerator matters too. A very high ratio caused only by nearly undetectable renin can be misleading if aldosterone is low, such as 4 ng/dL with renin 0.1 ng/mL/h. Most endocrine teams require a minimum aldosterone concentration before calling the screen positive.
If two reports look contradictory, check the unit line before worrying about disease progression. Our guide to different lab units shows why the same physiology can appear to change on paper.
Low potassium clues that make the result harder to ignore
Low potassium strengthens the suspicion of excess aldosterone because aldosterone increases potassium loss in the urine. Adult potassium is usually about 3.5-5.0 mmol/L, and a result below 3.5 mmol/L deserves explanation.
The misconception I still hear weekly is that primary aldosteronism always causes low potassium. It does not; many confirmed patients have potassium between 3.7 and 4.3 mmol/L, especially early in the disease or before diuretics are added.
A potassium of 3.0-3.4 mmol/L with hypertension is the zone where I slow down and check the medication list carefully. A level below 3.0 mmol/L, muscle weakness, palpitations, or ECG changes can become urgent, regardless of the aldosterone story.
Low potassium can also suppress aldosterone secretion and produce a false-negative screen. That odd detail matters: a patient can have primary aldosteronism, but if potassium is 2.9 mmol/L on collection day, aldosterone may look less impressive than expected.
If potassium is the abnormal value that brought you here, read our deeper guide to a low potassium result before increasing supplements on your own.
Medicines, salt and posture can flip the result
Blood pressure medicines, salt intake, potassium status, posture, and time of day can all change aldosterone and renin. This is why a repeat aldosterone test sometimes reverses the first result.
Spironolactone and eplerenone can raise renin and make ARR harder to interpret, so many specialists hold them for 4-6 weeks if blood pressure and potassium allow. Amiloride, triamterene, and loop or thiazide diuretics often need about 2-4 weeks, but stopping these drugs without supervision can be unsafe.
Beta blockers and clonidine suppress renin and can create false-positive ratios. ACE inhibitors and ARBs often raise renin and can create false-negative ratios; calcium channel blockers and alpha blockers are sometimes used as temporary substitutes because they usually disturb ARR less.
Salt restriction is another trap. If a patient has been eating below 1.5 g sodium per day, renin and aldosterone may rise together, while a normal-salt diet often makes autonomous aldosterone easier to identify.
When blood pressure medication has recently changed, potassium should be rechecked within a practical window, often 1-2 weeks for higher-risk patients. Our guide to BP medicine changes explains the potassium timing side of that decision.
What to ask before repeating an abnormal screening test
Before repeating an abnormal aldosterone-renin screen, ask whether potassium was corrected, salt intake was adequate, medicines were reviewed, and the sample was drawn in the lab’s required posture. Those four details prevent many false alarms.
My practical checklist is short: potassium above 3.5 mmol/L, no severe sodium restriction, morning collection, and a documented seated or supine rest period. Some laboratories ask for patients to be upright for at least 2 hours and seated for 5-15 minutes before collection; others use a supine protocol.
Kantesti is an AI lab test interpretation service that prompts users to enter medication and collection context when ARR looks unusual. That extra history can change the suggested next question from “Do I have an adrenal tumour?” to “Was renin suppressed because of beta blocker timing?”
Ask whether the same laboratory and assay will be used. A repeat at a different lab can be valid, but it should be interpreted as a fresh test rather than a clean trend line if aldosterone or renin methods changed.
If you are deciding whether to repeat now or wait, our guide to repeat abnormal labs covers the broader logic I use for borderline values.
Confirmatory tests after a positive aldosterone renin ratio
A positive aldosterone renin ratio is usually followed by a confirmatory suppression test unless the biochemical pattern is very strong. The goal is to prove aldosterone does not suppress when salt or medication signals should suppress it.
The saline infusion test commonly gives 2 litres of 0.9% saline over 4 hours under supervision. In many protocols, aldosterone above 10 ng/dL afterward supports primary aldosteronism, while below 5 ng/dL argues against it; seated protocols may use different thresholds.
Oral sodium loading checks 24-hour urinary aldosterone after high sodium intake, often requiring urine sodium above 200 mEq/day to prove the challenge was adequate. A urine aldosterone above about 12 µg/24 hours is often considered supportive, but heart failure, kidney disease, and severe hypertension can make this test risky.
Captopril challenge uses 25-50 mg captopril and measures whether aldosterone falls appropriately over 1-2 hours. It is easier to perform than fludrocortisone suppression, but borderline cases still create disagreement between clinicians.
Kidney function and volume tolerance decide which confirmation is safe. A patient with reduced eGFR or fluid overload needs a more cautious plan, and our renal function panel guide explains the baseline kidney markers usually reviewed first.
When scans and adrenal vein sampling enter the conversation
Imaging is considered after biochemical confirmation, not before it. A CT scan can show adrenal anatomy, but adrenal vein sampling is often needed to tell unilateral aldosterone production from bilateral adrenal overactivity.
This is a place where patients understandably get whiplash. A 9 mm adrenal nodule on CT may be unrelated, while a normal-looking adrenal gland can still overproduce aldosterone; age-related nonfunctioning nodules become more common after 40.
Adrenal vein sampling measures aldosterone and cortisol from both adrenal veins and compares sides. Cortisol is used to confirm catheter position, so a normal cortisol result elsewhere in your blood work does not replace the procedure.
Surgery is usually discussed when unilateral disease is proven and the patient is a suitable operative candidate. Bilateral disease is usually treated medically with mineralocorticoid receptor blockers such as spironolactone or eplerenone.
For readers comparing adrenal hormones, our cortisol pattern guide explains why different adrenal tests answer very different questions.
When high aldosterone is not primary aldosteronism
High aldosterone is not primary aldosteronism when renin is also high or appropriately activated. That pattern often points toward kidney artery narrowing, diuretic effect, dehydration, heart failure, liver fluid retention, or severe sodium restriction.
Secondary hyperaldosteronism is the body trying to defend circulation. A renin of 6 ng/mL/h with aldosterone 35 ng/dL is usually not the same disease as renin 0.2 ng/mL/h with aldosterone 18 ng/dL.
Kidney artery stenosis can drive renin from the under-perfused kidney, causing high aldosterone and difficult hypertension. The clue may be a sudden creatinine rise after ACE inhibitor or ARB therapy, an abdominal bruit, or asymmetric kidney size on imaging.
Diuretics are the everyday mimic. I have seen ARR referrals where the entire pattern was explained by a thiazide started 10 days earlier, with potassium 3.2 mmol/L and renin appropriately high.
If creatinine, eGFR, or urine albumin are also changing, read our guide to kidney blood tests before assuming the adrenal gland is the only problem.
Special situations: pregnancy, cycles, kidney disease and age
Pregnancy, estrogen therapy, menstrual timing, kidney disease, and older age can change renin or aldosterone interpretation. In these situations, the same numeric ARR may have a different level of reliability.
Pregnancy raises renin and aldosterone substantially, so primary aldosteronism can be harder to detect biochemically. Severe hypertension with potassium below 3.5 mmol/L in pregnancy is never a casual finding, but the diagnostic pathway needs obstetric and endocrine supervision.
Estrogen-containing therapy can alter renin measurements, particularly direct renin assays, and may create a false-positive ARR in some laboratories. The evidence is not perfectly tidy here, so I ask the lab which renin method was used before advising a repeat.
Kantesti’s hormone content team discusses timing issues in our research-linked women’s hormone guide, because endocrine tests are rarely detached from life stage. For blood pressure thresholds during pregnancy, our pregnancy pressure guide is more specific.
Older adults add another wrinkle: renin often runs lower with age, kidney stiffness, and long-standing hypertension. That can inflate ARR, so the aldosterone concentration, medication list, and clinical picture carry more weight than the ratio alone.
Questions to bring to your clinician before treatment
Before treatment, ask whether primary aldosteronism is confirmed, whether it appears unilateral or bilateral, and how potassium, kidney function, and blood pressure will be monitored. Treatment decisions should not rest on a single screening ratio.
Spironolactone often starts around 12.5-25 mg daily and is adjusted slowly, while eplerenone may be used when breast tenderness, menstrual effects, or sexual side effects are a problem. Potassium and creatinine are commonly rechecked within 1-2 weeks after dose changes in higher-risk patients.
Ask what success means for you. Some patients normalize potassium within days but need months for blood pressure improvement; others still need two medications after surgery because vascular stiffness and long-standing hypertension do not vanish overnight.
Monticone and colleagues reported higher cardiovascular risk in primary aldosteronism than in essential hypertension with similar blood pressure, including more stroke, atrial fibrillation, and heart damage (Monticone et al., 2018). That is why I do not dismiss “mild” aldosterone excess when the pattern is consistent.
Our doctors and advisors review endocrine-hypertension content through Kantesti’s medical advisory board. Thomas Klein, MD, also recommends bringing a written medication timeline, not just a pill list, to the appointment.
How Kantesti reads aldosterone in a whole-panel pattern
Kantesti reads aldosterone as part of a multi-marker pattern that includes renin, potassium, sodium, bicarbonate, creatinine, medications, and trend history. That approach reduces overreaction to isolated hormone flags.
Kantesti is an AI-powered blood test analysis tool used by 2M+ people across 127+ countries, and aldosterone interpretation is exactly the kind of case where context beats a green-or-red flag. A result of 16 ng/dL can be routine, suspicious, or uninterpretable depending on renin, potassium, salt intake, and medicines.
Our AI does not diagnose primary aldosteronism from an uploaded PDF. It flags patterns that deserve clinician discussion, such as suppressed renin with aldosterone above 15 ng/dL and potassium below 3.5 mmol/L, then explains what could distort the result.
If you want the engineering side, our technology guide describes how structured lab values are parsed from photos and PDFs. Our medical validation page explains the clinical review standards behind risk flagging.
For people tracking more than one hormone or electrolyte over time, the biomarkers guide is the better home base than a single-marker article. Trend direction matters: a potassium drift from 4.2 to 3.5 mmol/L over 18 months is not the same as one random 3.5.
Research notes and what still remains uncertain
The strongest evidence supports screening selected hypertensive patients, confirming positive screens, and subtyping confirmed primary aldosteronism before surgery. The uncertain part is where to draw the line for mild autonomous aldosterone excess.
The field is shifting away from a binary model. Brown et al. showed a continuum of renin-independent aldosterone production, which matches what I see clinically: some patients do not meet classic thresholds, yet their low-renin hypertension and potassium drift look biologically meaningful.
Kantesti LTD, described on our about us page, funds internal clinical validation work but keeps patient-facing interpretation conservative for YMYL medical content. We would rather tell a user “ask about repeat ARR conditions” than imply a diagnosis that needs endocrine confirmation.
Our population-scale AI evaluation is published as the clinical validation benchmark, and it includes hyperdiagnosis trap cases where over-calling disease is scored as an error. That matters for aldosterone because false certainty can lead to unnecessary scans, anxiety, and medication changes.
Bottom line: if your aldosterone is high, ask for the renin, potassium, medications, posture, and units before asking for a scan. That five-part question prevents many wrong turns.
Frequently Asked Questions
What aldosterone level is concerning for primary aldosteronism?
An aldosterone level is concerning when it is inappropriately high while renin is suppressed, not just because it is above the reference range. Many clinicians become suspicious when aldosterone is at least 10-15 ng/dL with plasma renin activity below 1.0 ng/mL/h and an aldosterone renin ratio above 20-30. A value above 20 ng/dL with clearly suppressed renin and hypertension is a stronger pattern. The laboratory method, posture, salt intake, and medications still have to be checked.
Why is a renin test ordered with an aldosterone test?
A renin test is ordered with an aldosterone test because renin shows whether aldosterone is responding appropriately to kidney-volume signals. High aldosterone with high renin often suggests secondary activation, such as diuretics, dehydration, or kidney artery narrowing. High aldosterone with low renin suggests autonomous aldosterone production and raises concern for primary aldosteronism. The ratio is usually more informative than either number alone.
Can primary aldosteronism happen with normal potassium?
Yes, primary aldosteronism can happen with normal potassium. Adult potassium is usually about 3.5-5.0 mmol/L, and many confirmed primary aldosteronism patients remain within that range, especially early on. Low potassium below 3.5 mmol/L makes the diagnosis more suspicious, but normal potassium does not rule it out. Resistant hypertension with suppressed renin is enough reason to discuss screening in many patients.
Do blood pressure medicines affect the aldosterone renin ratio?
Yes, several blood pressure medicines can affect the aldosterone renin ratio. Spironolactone, eplerenone, amiloride, triamterene, and diuretics can raise renin and may create false-negative or hard-to-read results. Beta blockers and clonidine can suppress renin and may create false-positive ratios. ACE inhibitors and ARBs often raise renin, so any medication change before testing should be supervised rather than done alone.
Should spironolactone be stopped before repeating an aldosterone test?
Spironolactone is often held for 4-6 weeks before aldosterone-renin testing if it is safe to do so, because it directly blocks mineralocorticoid receptors and can raise renin. Eplerenone is handled similarly in many protocols. Patients with severe hypertension, heart failure, kidney disease, or potassium instability should not stop it without a clinician’s plan. Safer temporary substitutes may include verapamil SR, hydralazine, or alpha blockers in selected patients.
What confirmatory test is done after a positive aldosterone renin ratio?
Confirmatory testing after a positive aldosterone renin ratio may include saline infusion, oral sodium loading, captopril challenge, or fludrocortisone suppression. In one common saline infusion protocol, 2 litres of 0.9% saline are given over 4 hours, and aldosterone above 10 ng/dL afterward supports primary aldosteronism. Oral sodium loading often requires urine sodium above 200 mEq/day to prove adequate salt intake. The safest test depends on kidney function, heart status, blood pressure severity, and potassium.
Is primary aldosteronism curable?
Primary aldosteronism can sometimes be functionally cured or greatly improved when one adrenal gland is the source and surgery is appropriate. Bilateral disease is usually treated with mineralocorticoid receptor blockers such as spironolactone or eplerenone rather than surgery. Potassium may normalize quickly, but blood pressure can take months to improve and may not fully normalize if hypertension has been present for years. Subtyping with imaging and often adrenal vein sampling helps decide the treatment route.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Women's Health Guide: Ovulation, Menopause & Hormonal Symptoms. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Clinical Validation of the Kantesti AI Engine (2.78T) on 100,000 Anonymised Blood Test Cases Across 127 Countries: A Pre-Registered, Rubric-Based, Population-Scale Benchmark Including Hyperdiagnosis Trap Cases — V11 Second Update. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.